
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
5/5/2025
0:00
21:13
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
Altri episodi di "JAMA Neurology Author Interviews"



Non perdere nemmeno un episodio di “JAMA Neurology Author Interviews”. Iscriviti all'app gratuita GetPodcast.







